Stanford Hospital and Clinics

Palo Alto, California 94305

4 studies enrolling now · 33 studies all time

What they study most

Acute Respiratory Viral Infection, Advanced Solid Tumor, Alzheimer's Disease, Alzheimer's Disease Dementia, Aortic Stenosis, Apnea, Behavior Change Techniques, Breast Cancer, Chronic Ischemic Left Ventricular Dysfunction, Colorectal Cancer, Epstein-Barr Viraemia, Epstein-Barr Virus Infections

Studies at this site

• Blossom® Smart Expander Device for Tissue Expander/Implant-Based Breast Reconstruction — Recruiting now
• Assessment of the Interi Manifold in Implant-Based Breast Reconstruction — Recruiting now
• Evaluation of Combination Therapy for Upper Extremity Lymphedema — Recruiting now
• Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left Ventricular Dysfunction — Recruiting now
• A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis — Running, not enrolling
• A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
• Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma — Completed
• School-Based Bladder Health Intervention — Withdrawn before enrolling
• Treatment of Adult Traumatic Rib Fractures With Percutaneous Cryoneurolysis — Completed
• Early Percutaneous Cryoablation for Pain Control After Rib Fractures Among Elderly Patients — Completed
• PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis — Running, not enrolling
• Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy — Completed
• A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early
• Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) — Completed
• A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness — Completed
• A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 — Stopped early
• Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients — Stopped early
• Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC) — Stopped early
• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration — Completed
• VR for Surgical Prehabilitation and Rehabilitation — Status unconfirmed
• A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis — Stopped early
• A Study of PY314 in Subjects With Advanced Solid Tumors — Stopped early
• Feasibility of Text4US Program — Stopped early
• Investigation of Novel Surgical Imaging for Tumor Excision — Completed
• Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1 — Completed
• Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease — Stopped early
• Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes — Completed
• Lidocaine Infusions for Rib Fractures — Withdrawn before enrolling
• PARTNER II Trial: S3iCAP — Completed
• Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study — Completed
• Rates of Apnea in Patients Undergoing Vitreoretinal Surgery — Completed
• Feasibility of a Mobile Electronic Mindfulness Therapy Service for Chronic Pancreatitis — Completed
• Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2) — Completed